Stocksigma LogoStocksigma Logo

Advanced Enzyme Technologies Reports Strong Q2 FY27 Performance Driven by Bio-Processing Growth

Advanced Enzyme Technologies reported consolidated revenue from operations of ₹2,145 mn for Q2 FY27, up 16% YoY and 12% QoQ, while H1 FY27 revenue rose 10%

Advanced Enzyme Technologies Reports Strong Q2 FY27 Performance Driven by Bio-Processing Growth

Advanced Enzyme Technologies Ltd · Investor Presentation · 31 Oct 2026, 9:18 pm

Advanced Enzyme Technologies Reports Strong Q2 FY27 Performance Driven by Bio-Processing Growth Advanced Enzyme Technologies reported consolidated revenue from operations of ₹2,145 mn for Q2 FY27, up 16% YoY and 12% QoQ, while H1 FY27 revenue rose 10% YoY to ₹4,062 mn. Q2 FY27 EBITDA grew 20% YoY (36% QoQ) to ₹721 mn with a 34% margin, and PAT increased 14% YoY (33% QoQ) to ₹512 mn (24% margin). Growth was led by Industrial Bio-processing (+43% YoY to ₹365 mn) and Animal Nutrition (+37% YoY to ₹265 mn). India contributed 52% of Q2 revenue (+25% YoY).

Original exchange filing (PDF)

More announcements from Advanced Enzyme Technologies Ltd

All Advanced Enzyme Technologies Ltd announcements